|HIV/AIDS Antiretrovirals for Treatment
The AIDS Clinical Trials Unit (ACTU) at Mount Sinai Beth Israel has
been conducting studies under the auspices of the National Institute of
Allergy and Infectious Diseases (NIAID), a division of the National
Institutes of Health, and the pharmaceutical industry since 1987. Over the
past 12 years, we have participated in numerous trials that led to the
approval of many of the treatments that are now commonly used to treat
HIV infection and the associated opportunistic infections.
We are currently participating in trials that are evaluating new
investigational drugs and well as ones that are FDA approved. Studies
are available for patients without previous anti-HIV drug experience and
for patients who have been previously treated, including salvage therapy
Criteria for Participation:
Adults (18 year of age and older) who are HIV-positive.